Stereotaxis CEO David Fischel says the MAGiC catheter was designed "to overcome the natural limitations of manual pull-wire ...
Vektor Medical, a medical technology company transforming cardiac arrhythmia care, announced key milestones achieved in 2025, a year defined by progress, innovation, and growth. Vektor's flagship ...
"Publication of the new AMA CPT code represents a significant milestone for Sensydia, and will help foster the adoption of our nninvasive, in-clinic hemodynamic assessment tool by establishing a ...
Stereotaxis plans to launch the MAGiC cardiac ablation catheter in early 2026, CEO and Chair David Fischel tells MassDevice.
Researchers at RIT are developing non-invasive technology that will better assess cardiac tissue response to thermal energy, a common therapy approach for both cancer and cardiac arrhythmia treatments ...
PolyVascular, a medtech company developing a non-surgical heart valve for children with congenital heart disease, has obtained $2 million in funding from non-profit pediatric initiative, CobiCure ...
Auricular vagal neuromodulation therapy is a non-invasive and non-surgical treatment that could aid cardiovascular disease ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback